85-4453-41 [取扱停止]Interleukin-36 alpha, active (IL36A), Recombinant, Human 100ug 348129
特徴
- Cytokine that binds to and signals through the IL1RL2/IL-36R receptor which in turn activates NF-kappa-B and MAPK signaling pathways in target cells linked to a pro-inflammatory response. Part of the IL-36 signaling system that is thought to be present in epithelial barriers and to take part in local inflammatory response; similar to the IL-1 system with which it shares the coreceptor IL1RAP. Seems to be involved in skin inflammatory response by acting on keratinocytes, dendritic cells and indirectly on T cells to drive tissue infiltration, cell maturation and cell proliferation. In cultured keratinocytes induces the expression of macrophage, T cell, and neutrophil chemokines, such as CCL3, CCL4, CCL5, CCL2, CCL17, CCL22, CL20, CCL5, CCL2, CCL17, CCL22, CXCL8, CCL20 and CXCL1, and the production of proinflammatory cytokines such as TNF-alpha, IL-8 and IL-6. In cultured monocytes upregulates expression of IL-1A, IL-1B and IL-6. In myeloid dendritic cells involved in cell maturation by upregulating surface expression of CD83, CD86 and HLA-DR. In monocyte-derived dendritic cells facilitates dendritic cell maturation and drives T cell proliferation. May play a role in proinflammatory effects in the lung. {ECO:0000269|PubMed:14734551, ECO:0000269|PubMed:21881584, ECO:0000269|PubMed:21965679, ECO:0000269|PubMed:24829417}.
- Biological Activity:Fully biologically active when compared to standard. The ED50 as determined by inducing IL-8 secretion in human preadipocytes is less than 10ng/ml, corresponding to a specific activity of > 1.0x10e5 IU/mg.
- Sequence:KIDTPQQGSI QDINHRVWVL QDQTLIAVPR KDRMSPVTIA LISCRHVETL EKDRGNPIYL GLNGLNLCLM CAKVGDQPTL QLKEKDIMDL YNQPEPVKSF LFYHSQSGRN STFESVAFPG WFIAVSSEGG CPLILTQELG KANTTDFGLT MLF
- Molecular Weight:17.1kD
- PubMed ID:10625660; 11991722; 14702039; 15815621; 15489334; 11466363; 14734551; 16777052; 21965679; 21881584; 24829417
- Gene Name:IL36A,FIL1E,IL1E,IL1F6
- Swiss Prot:Q9UHA7
- Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile PBS. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
仕様
- Size:100ug
- Source Antigen:Recombinant, Human, E. coli
- Grade:Highly Purified
- Purity:≥95% as determined by SDS-PAGE and HPLC.
- Form:Lyophilized from 0.2um filtered 20mM Tris, 300mM NaCl, pH 8.0, 0.1% Tween 80
- Molecular Weight Non Ab:17.1
- Swiss Prot Number:Q9UHA7
- EU Commodity Code:30021019
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
| 商品イメージ | アズワン品番 商品名 |
|---|---|
|
85-4453-42
Interleukin-36 alpha, active (IL36A), Recombinant, Human 250ug
|
|
|
85-4453-39
Interleukin-36 alpha, active (IL36A), Recombinant, Human 2ug
|
|
|
85-4453-41
Interleukin-36 alpha, active (IL36A), Recombinant, Human 100ug
|
|
|
85-4453-40
Interleukin-36 alpha, active (IL36A), Recombinant, Human 10ug
|
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





